Wealth Enhancement Advisory Services LLC Purchases New Position in U.S. Physical Therapy, Inc. $USPH

Key Points

• Wealth Enhancement Advisory Services LLC has purchased a new stake in U.S. Physical Therapy, acquiring 4,153 shares valued at approximately $341,000 in the second quarter.
• Analysts have mixed opinions on U.S. Physical Therapy, with ratings ranging from "buy" to "hold," and a consensus target price of $110.25, as reported by various research firms.
• U.S. Physical Therapy recently announced a quarterly dividend of $0.45 per share, representing an annual yield of 2.0% and a payout ratio of 78.60%.

Wealth Enhancement Advisory Services LLC purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 4,153 shares of the company's stock, valued at approximately $341,000.

Other large investors have also made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of U.S. Physical Therapy by 952.4% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after buying an additional 400 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of U.S. Physical Therapy by 90.6% in the 2nd quarter. Parallel Advisors LLC now owns 448 shares of the company's stock valued at $35,000 after buying an additional 213 shares in the last quarter. Fifth Third Bancorp grew its stake in shares of U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after buying an additional 265 shares in the last quarter. AlphaQuest LLC bought a new stake in shares of U.S. Physical Therapy in the 1st quarter valued at approximately $92,000. Finally, First Horizon Advisors Inc. grew its stake in shares of U.S. Physical Therapy by 35.0% in the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock valued at $140,000 after buying an additional 500 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on USPH. Wall Street Zen lowered U.S. Physical Therapy from a "buy" rating to a "hold" rating in a report on Sunday, September 21st. Zacks Research raised U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. JPMorgan Chase & Co. assumed coverage on U.S. Physical Therapy in a research report on Thursday, September 18th. They set an "overweight" rating and a $110.00 target price for the company. Weiss Ratings reiterated a "hold (c)" rating on shares of U.S. Physical Therapy in a research note on Saturday, September 27th. Finally, Barrington Research raised their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research note on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

U.S. Physical Therapy Trading Up 0.6%

NYSE:USPH opened at $90.08 on Wednesday. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The business's 50-day moving average price is $82.65 and its two-hundred day moving average price is $77.05. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of 39.34, a PEG ratio of 4.49 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same quarter in the prior year, the firm posted $0.73 earnings per share. The company's quarterly revenue was up 18.0% on a year-over-year basis. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.0%. U.S. Physical Therapy's dividend payout ratio is presently 78.60%.

Insider Transactions at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 698 shares of the stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares in the company, valued at approximately $2,394,546.88. This trade represents a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the completion of the transaction, the chief executive officer owned 114,088 shares of the company's stock, valued at approximately $9,529,770.64. This represents a 1.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,853 shares of company stock valued at $581,406. Corporate insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.